GNS Healthcare, Dana-Farber and Mount Sinai Collaborate to Build Computer Model of Multip... ( CAMBRIDGE Mass. BOSTON and NEW YORK N...)

GNS Healthcare, Dana-Farber and Mount Sinai Collaborate to Build Computer Model of Multiple Myeloma

Date:11/8/2012

CAMBRIDGE, Mass., BOSTON and NEW YORK, Nov. 8, 2012 /PRNewswire/ -- GNS Healthcare, Inc. (GNS), the leading healthcare data analytics company focused on enabling personalized medicine to improve human health, today announced that it has entered into a collaboration with Dana-Farber Cancer Institute (Dana-Farber) and Mount Sinai School of Medicine (Mount Sinai) to create a data-driven computer model of multiple myeloma, the second most common blood cancer in the U.S. that constitutes approximately one percent of all cancers. Created using GNS's supercomputer-driven REFS™ (Reverse Engineering and Forward Simulation) platform, the models will be used to help researchers discover novel therapies for the disease and to help determine the best existing treatments for patients.

"We have made encouraging progress at Dana-Farber Cancer Institute in using gene profiling, proteomic and signaling studies in tumor cell samples treated with existing and novel medicines to get a better understanding of myeloma pathogenesis and to develop novel targeted therapies," said Dr. Ken Anderson, Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at Dana-Farber and Kraft Family Professor of Medicine at Dana-Farber and Harvard Medical School.

"Because of this progress, our team is excited about deploying a powerful, supercomputer driven approach using our multi-layered genomic data to develop computer models to directly define the integrated underlying circuitry of myeloma. We look forward to using these models to identify, create, and implement better treatments for individual multiple myeloma patients," said Dr. Nikhil Munshi, Associate Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at Dana-Farber and Associate Professor of Medicine, Harvard Medical School
'/>"/>

SOURCE GNS Healthcare
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related biology technology :

1. Healthcare, Regulatory and Reimbursement Landscape - Australia
2. Cedars-Sinai researchers, with stem cells and global colleagues, develop Huntingtons research tool
3. Elsevier Collaborates With Infocomm Development Authority of Singapore and Top Academic Institutions to Bring CodeForScience to Singapore
4. ASAE, TMG Custom Media Collaborate to Launch New Print-Plus-Digital Strategy for Associations Now Magazine
5. Genetics Policy Institute (GPI) Collaborates on Second Midwest Conference on Stem Cell Biology and Therapy, Oct. 5-7 at Oakland University
6. uniQure Collaborates with UCSF on GDNF Gene Therapy in Parkinsons Disease
7. "Collaborate to Innovate" with Formedix at DIA Annual Meeting 2012
8. Ambrx Collaborates with Merck to Design and Develop Biologic Drug Conjugates
9. Goddard collaborates with international partners on MMS instrument
10. Elsevier Collaborates With Prophecy Healthcare to Enhance Its Staff Development Offerings for Healthcare Organizations
11. Accelerate Brain Cancer Cure and Exosome Diagnostics Collaborate to Advance Clinical Studies of Exosome Biofluid Molecular Diagnostics Technology in Brain Cancer

Post Your Comments:

(Date:5/22/2013)... 22, 2013 Cambridge Semantics was ... week’s “Data Demonstration Day” on Capitol Hill, hosted by The ... Google, Microsoft and others to showcase how innovative data management ... and Transparency Act (DATA Act). , Originally introduced in 2011 ... and Sen. Mark Warner (D-VA ), the ...

(Date:5/22/2013)... NEW YORK , May 22, 2013 /PRNewswire/ ... pioneering the development of disease modifying therapeutics for ... today the completion of its Series B financing, ... shares and warrants that would represent approximately $2.8M ... investors and new investors supported the raise. ...

(Date:5/22/2013)... May 22, 2013 Superior Controls, Inc. has ... by Business NH Magazine. For the past 22 ... that distinguish themselves with extraordinary business and civic ... receive this honor," said Rick Pierro ... any recognition, this award is a reflection of ...

(Date:5/22/2013)... Basel, Switzerland (PRWEB) May 22, 2013 ... solutions for industrial biotechnology, drug discovery, and life ... Genedata Selector ™ as its bioinformatics ... its production-relevant organisms. Genedata will provide AB Enzymes, ... manufacturers, with a hosted solution of Genedata Selector ...

Breaking Biology Technology:Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill 2 Oligomerix, Inc. Completes Series B Financing 2 Oligomerix, Inc. Completes Series B Financing 3 Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine 2 AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2 AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3 AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4

[0] Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill [0] Oligomerix, Inc. Completes Series B Financing [0] Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine [0] AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization

... facility to support clinical development for ... lead drug candidate and other molecules, ... radiopharmaceutical company that designs, develops and,manufactures products to detect, ... completed commissioning its in-house manufacturing,capability to meet clinical trial ...

... (OTC Bulletin Board: YGYB) ("Yongye" or the "Company"),a leading ... in the People,s Republic of China, today announced its ... Second Quarter 2008 Highlights -- Revenue was ... quarter of 2007, and an ...

... 15 The backpack is a back-to-school,staple. In ... fashion accessory as,well. However, backpacks are a leading ... children and adolescents. As students head back to ... preventing,unnecessary backpack pain and injuries., The MCA ...

Cellectar, Inc. Begins GMP Production Yongye Biotechnology International Announces Second Quarter Results Minnesota Chiropractic Association Offers Backpack Safety Checklist

(Date:5/22/2013)... Declines in the biodiversity of pollinating insects and wild ... new study. , Researchers led by the University of ... found evidence of dramatic reductions in the diversity ... the 1950s and 1980s. , But the picture brightened ... national biodiversity losses among bees, hoverflies and wild plants. ...

(Date:5/21/2013)... A new analysis shows that the nation,s land ... enough algae to produce up to 25 billion gallons ... one-twelfth of the country,s yearly needs. , The findings ... that would be needed to grow significant amounts of ... were published in the May 7 issue of ...

(Date:5/21/2013)... Water Center today awarded 12 research grants, totaling ... protection efforts. , The two-year grants of up ... to track the remediation of harmful algae blooms; ... weedy plant invasions; study chromosomal damage in tree ... activities. , The grants were awarded to multidisciplinary ...

Breaking Biology News(10 mins):Encouraging signs for bee biodiversity 2 Encouraging signs for bee biodiversity 3 Going green: Nation equipped to grow serious amounts of pond scum for fuel 2 Going green: Nation equipped to grow serious amounts of pond scum for fuel 3 Going green: Nation equipped to grow serious amounts of pond scum for fuel 4 U-M Water Center awards $570K in Great Lakes restoration grants 2 U-M Water Center awards $570K in Great Lakes restoration grants 3 U-M Water Center awards $570K in Great Lakes restoration grants 4

[0] Encouraging signs for bee biodiversity [0] Going green: Nation equipped to grow serious amounts of pond scum for fuel [0] U-M Water Center awards $570K in Great Lakes restoration grants

... A University of Minnesota Medical School research team ... offer a novel approach to ease the chronic and ... Using a mouse model of SCD, Gupta and University ... animals that exhibited both musculoskeletal pain and temperature sensitivity, ...

... EAST LANSING, Mich. A Michigan State University researcher ... parkin may help nerve cells fight off damage from ... therapies for the degenerative ailment. John Goudreau, an ... Unit, believes parkin can rescue certain neurons from injury ...

... a broad effort to achieve breakthrough innovations in energy production, ... award of up to $122 million over five years to ... Innovation Hub aimed at developing revolutionary methods to generate fuels ... Artificial Photosynthesis (JCAP), to be led by the California Institute ...

Cached Biology News:UM researcher identifies novel treatment for pain in sickle cell disease 2 Specific protein may help neurons fix themselves in Parkinson's patients 2 California team to receive up to $122 million to develop method to produce fuels from sunlight 2 California team to receive up to $122 million to develop method to produce fuels from sunlight 3

UM researcher identifies novel treatment for pain in sickle cell disease Specific protein may help neurons fix themselves in Parkinson's patients California team to receive up to $122 million to develop method to produce fuels from sunlight

... CyScribe GFX Purification Kit, 24 reactions. ... Cy3- and Cy5-labeled cDNA.Optimized reagents are ... and purification.Flexible and optimized protocols can ... with either Cy3- or Cy5-labeled nucleotides.Reliable ...

NORMAL DONOR DONKEY SERUM...

... 301 Power Supply, 1. 300 V, ... or constant current modes.Single-unit increments in ... reproducibility.Suitable for submarine, mini vertical, and ... as semidry and mini tank blotting ...

B3-1...

Biology Products:

CyScribe Post-Labeling Kit with CyScribe GFX Purification Kit from GE Healthcare, formerly Amersham Biosciences Normal Donor Donkey Serum - 500mL from Biomeda Corporation EPS 301 Power Supply from GE Healthcare, formerly Amersham Biosciences Mouse Anti-Bovine collagen type IX Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank